Literature DB >> 16469322

Mild folate deficiency induces a proatherosclerotic phenotype in endothelial cells.

Karen S Brown1, Yuehua Huang, Zhi-Yong Lu, Wenying Jian, Ian A Blair, Alexander S Whitehead.   

Abstract

Low folate/high homocysteine (Hcy) is an established risk marker for cardiovascular disease (CVD). Some in vivo studies suggest low folate may independently contribute to CVD. To study the effects of mild folate deficiency on endothelial function, we adapted the EA.hy 926 endothelial cell line to growth in medium containing 23 nM folic acid (LO cells) or 9 microM folic acid (HI cells). Folate derivatives were substantially depleted in LO cells relative to HI cells. No differences were seen in intracellular homocysteine, S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), the SAM:SAH ratio, or global DNA methylation, and there was no consistent difference in secreted homocysteine. A greater percentage of LO than HI cells were in S phase of the cell cycle; supplementation of LO cells with thymidine/hypoxanthine prevented this. LO cells were more elongated than HI cells and did not form tight monolayers. Stress fibers were very prominent in LO but not HI cells. Treatment of LO cells with rho kinase inhibitors abolished stress fibers and partially normalized cell shape. LO cell monolayers were more permeable than HI cell monolayers at confluence, and MCP-1 mRNA and protein expression was higher in LO than HI cells. Our results suggest that mild folate deficiency is proatherosclerotic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469322     DOI: 10.1016/j.atherosclerosis.2005.12.018

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

Review 1.  Stable-isotope dilution LC–MS for quantitative biomarker analysis.

Authors:  Eugene Ciccimaro; Ian A Blair
Journal:  Bioanalysis       Date:  2010-02       Impact factor: 2.681

2.  Pemetrexed alters folate phenotype and inflammatory profile in EA.hy 926 cells grown under low-folate conditions.

Authors:  Andrea L Hammons; Carolyn M Summers; Jeanine Jochems; Jasbir S Arora; Suhong Zhang; Ian A Blair; Alexander S Whitehead
Journal:  Eur J Pharmacol       Date:  2012-09-05       Impact factor: 4.432

Review 3.  Neural tube defects, folate, and immune modulation.

Authors:  Kerina J Denny; Angela Jeanes; Kristin Fathe; Richard H Finnell; Stephen M Taylor; Trent M Woodruff
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-09

4.  Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells.

Authors:  Carolyn M Summers; Andrea L Hammons; Jasbir Arora; Suhong Zhang; Jeanine Jochems; Ian A Blair; Alexander S Whitehead
Journal:  Eur J Pharmacol       Date:  2014-03-18       Impact factor: 4.432

5.  Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels of monocyte chemoattractant protein-1.

Authors:  Andrea L Hammons; Carolyn M Summers; Jayne V Woodside; Helene McNulty; J J Strain; Ian S Young; Liam Murray; Colin A Boreham; John M Scott; Laura E Mitchell; Alexander S Whitehead
Journal:  Clin Immunol       Date:  2009-07-21       Impact factor: 3.969

6.  Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor.

Authors:  Zhi-Yong Lu; Megan Morales; Stephanie Khartulyari; Minghua Mei; Kristen M Murphy; Anna Stanislawska-Sachadyn; Carolyn M Summers; Yuehua Huang; Joan M Von Feldt; Ian A Blair; Laura E Mitchell; Alexander S Whitehead
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-10

7.  Quantification of key red blood cell folates from subjects with defined MTHFR 677C>T genotypes using stable isotope dilution liquid chromatography/mass spectrometry.

Authors:  Yuehua Huang; Stefanie Khartulyari; Megan E Morales; Anna Stanislawska-Sachadyn; Joan M Von Feldt; Alexander S Whitehead; Ian A Blair
Journal:  Rapid Commun Mass Spectrom       Date:  2008-08       Impact factor: 2.419

8.  The up-regulation of monocyte chemoattractant protein-1 (MCP-1) in Ea.hy 926 endothelial cells under long-term low folate stress is mediated by the p38 MAPK pathway.

Authors:  Zhi-Yong Lu; Liselotte E Jensen; Yuehua Huang; Carmel Kealey; Ian A Blair; Alexander S Whitehead
Journal:  Atherosclerosis       Date:  2008-12-13       Impact factor: 5.162

9.  Association between low-dose folic acid supplementation and blood lipids concentrations in male and female subjects with atherosclerosis risk factors.

Authors:  Artur Mierzecki; Karolina Kłoda; Hanna Bukowska; Kornel Chełstowski; Magdalena Makarewicz-Wujec; Małgorzata Kozłowska-Wojciechowska
Journal:  Med Sci Monit       Date:  2013-09-04

10.  Effect of folic acid supplementation in pregnancy on preeclampsia: the folic acid clinical trial study.

Authors:  Shi Wu Wen; Josee Champagne; Ruth Rennicks White; Doug Coyle; William Fraser; Graeme Smith; Dean Fergusson; Mark C Walker
Journal:  J Pregnancy       Date:  2013-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.